Impact of Smaller Target Volumes in Head and Neck Cancer Treatment
Author Information
Author(s): Micah T. Monaghan, James A. Bonner, Philip E. Schaner, Jimmy J. Caudell
Primary Institution: The University of Alabama at Birmingham
Hypothesis
Smaller target volumes may result in improved normal tissue sparing without compromising locoregional control in head and neck cancer.
Conclusion
Smaller target volumes with the addition of an intermediate dose volume results in improved sparing of most normal tissues.
Supporting Evidence
- Smaller target volumes led to significantly lower doses to normal tissues like the parotid and mandible.
- The mean dose to the contralateral parotid was reduced in the 3Dose plans.
- No significant difference in locoregional control was found between the two planning methods.
Takeaway
Using smaller areas to target cancer can help protect healthy parts of the body during treatment.
Methodology
Ten patients with Stage III-IV head and neck cancer were treated using two different planning methods: RTOG 0522 and a three dose level plan (3Dose) with smaller target volumes.
Potential Biases
Potential biases may arise from the selection of patients and the retrospective nature of the study.
Limitations
The study is retrospective and based on a small sample size of ten patients.
Participant Demographics
Patients had Stage III-IV head and neck cancer, with various primary sites including oropharynx, hypopharynx, and larynx.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website